Companies / Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc.
OBXCIK 2130606
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Ross Robert W. Director | Grant Grant or award | Stock Option (Right to Buy) | — | +38K | 37,653 | low |
| Aug 3, 2026 | Norkunas Matthew Director | Grant Grant or award | Stock Option (Right to Buy) | — | +38K | 37,653 | low |
| Aug 3, 2026 | Jagasia Madan CEO | Grant Grant or award | Stock Option (Right to Buy) | — | +38K | 37,653 | low |
| Aug 3, 2026 | Barrett Peter Director | Grant Grant or award | Stock Option (Right to Buy) | — | +38K | 37,653 | low |
| Aug 3, 2026 | Hagen Heidi Director | Grant Grant or award | Stock Option (Right to Buy) | — | +38K | 37,653 | low |
| Aug 3, 2026 | Fardis Maria Director | Grant Grant or award | Stock Option (Right to Buy) | — | +38K | 37,653 | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| OBX | unknown | 67448A106 |